David B. Donner - Publications

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Immunology, Oncology, Molecular Biology

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Antonia RJ, Karelehto E, Toriguchi K, Matli M, Warren RS, Pfeffer LM, Donner DB. STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. Journal of Cellular and Molecular Medicine. 26: 4591-4601. PMID 35841281 DOI: 10.1111/jcmm.17489  0.334
2018 Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, et al. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-Resistant Tumors. Molecular Cancer Therapeutics. PMID 30254185 DOI: 10.1158/1535-7163.Mct-17-1204  0.307
2015 Depeille P, Henricks LM, van de Ven RA, Lemmens E, Wang CY, Matli M, Werb Z, Haigis KM, Donner D, Warren R, Roose JP. RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth. Nature Cell Biology. 17: 804-15. PMID 26005835 DOI: 10.1038/Ncb3175  0.324
2014 Ducker GS, Atreya CE, Simko JP, Hom YK, Matli MR, Benes CH, Hann B, Nakakura EK, Bergsland EK, Donner DB, Settleman J, Shokat KM, Warren RS. Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 33: 1590-600. PMID 23542178 DOI: 10.1038/Onc.2013.92  0.394
2014 Depeille P, Henricks LM, Ven Rvd, Lemmens E, Matli M, Haigis KM, Donner D, Warren R, Roose JP. Abstract LB-306: The Ras exchange factor RasGRP1 opposes proliferative EGFR-SOS1 Ras signals and restricts intestinal epithelial cell growth Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-306  0.323
2013 Farkas C, Martins CP, Escobar D, Hepp MI, Castro AF, Evan G, Gutiérrez JL, Warren R, Donner DB, Pincheira R. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress. Plos One. 8: e73817. PMID 24040083 DOI: 10.1371/Journal.Pone.0073817  0.374
2013 Farkas C, Martins C, Escobar D, Castro A, Donner D, Pincheira R. Abstract LB-51: p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-51  0.368
2012 Ducker GS, Atreya CE, Simko J, Nakakura EK, Bergsland EK, Donner DB, Shokat KM, Warren RS. Effect of PIK3CA and KRAS mutations on sensitivity to ATP-competitive mTOR inhibitors in a primary xenograft model of colorectal carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 483. PMID 27982970 DOI: 10.1200/Jco.2012.30.4_Suppl.483  0.322
2011 Lin CI, Barletta JA, Nehs MA, Morris ZS, Donner DB, Whang EE, Jeong JW, Kimura S, Moore FD, Ruan DT. Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. Surgery. 150: 1295-302. PMID 22136853 DOI: 10.1016/J.Surg.2011.09.014  0.409
2011 Mitra R, Guo Z, Milani M, Mesaros C, Rodriguez M, Nguyen J, Luo X, Clarke D, Lamba J, Schuetz E, Donner DB, Puli N, Falck JR, Capdevila J, Gupta K, et al. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). The Journal of Biological Chemistry. 286: 17543-59. PMID 21402692 DOI: 10.1074/Jbc.M110.198515  0.353
2011 Lin CI, Du J, Shen WT, Whang EE, Donner DB, Griff N, He F, Moore FD, Clark OH, Ruan DT. Mitogen-inducible gene-6 is a multifunctional adaptor protein with tumor suppressor-like activity in papillary thyroid cancer. The Journal of Clinical Endocrinology and Metabolism. 96: E554-65. PMID 21190978 DOI: 10.1210/Mend.25.2.Zmg373A  0.34
2010 Lin CI, Whang EE, Donner DB, Du J, Lorch J, He F, Jiang X, Price BD, Moore FD, Ruan DT. Autophagy induction with RAD001 enhances chemosensitivity and radiosensitivity through Met inhibition in papillary thyroid cancer. Molecular Cancer Research : McR. 8: 1217-26. PMID 20736296 DOI: 10.1158/1541-7786.Mcr-10-0162  0.363
2010 Wang YC, Zuraek MB, Kosaka Y, Ota Y, German MS, Deneris ES, Bergsland EK, Donner DB, Warren RS, Nakakura EK. The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestine. Endocrine-Related Cancer. 17: 283-91. PMID 20048018 DOI: 10.1677/Erc-09-0243  0.304
2010 Nakakura E, Wong M, Wang Y, Iezza G, Zuraek M, Yuan X, Donner D, Hanahan D, Warren R, Bergsland E. Distinct mTOR Pathway Activity in Neuroendocrine Tumors of the Pancreas and Small Intestine Revealed by Immunohistochemical Analysis Pancreas. 39: 276. DOI: 10.1097/01.Mpa.0000363927.24091.1C  0.35
2010 Nakakura E, Iezza G, Zuraek M, Jablons D, Theodore P, Donner D, Bergsland E, Warren R, Wang Y. Lack of NKX2.2 Transcription Factor Expression Distinguishes Bronchopulmonary Typical Carcinoids from Gastrointestinal Neuroendocrine Tumors Journal of Surgical Research. 158: 267. DOI: 10.1016/J.Jss.2009.11.270  0.324
2010 Nakakura E, Zuraek M, Donner D, Bergsland E, Warren R, Wang Y. Reduced GFI1 Transcription Factor Expression in Small Intestinal Neuroendocrine Tumor Metastases Journal of Surgical Research. 158: 266-267. DOI: 10.1016/J.Jss.2009.11.269  0.316
2009 Lin CI, Whang EE, Donner DB, Jiang X, Price BD, Carothers AM, Delaine T, Leffler H, Nilsson UJ, Nose V, Moore FD, Ruan DT. Galectin-3 targeted therapy with a small molecule inhibitor activates apoptosis and enhances both chemosensitivity and radiosensitivity in papillary thyroid cancer. Molecular Cancer Research : McR. 7: 1655-62. PMID 19825987 DOI: 10.1158/1541-7786.Mcr-09-0274  0.345
2009 Satpathy M, Shao M, Emerson R, Donner DB, Matei D. Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity. The Journal of Biological Chemistry. 284: 15390-9. PMID 19324884 DOI: 10.1074/Jbc.M808331200  0.337
2009 Pincheira R, Baerwald M, Dunbar JD, Donner DB. Sall2 is a novel p75NTR-interacting protein that links NGF signalling to cell cycle progression and neurite outgrowth. The Embo Journal. 28: 261-73. PMID 19131967 DOI: 10.1038/Emboj.2008.274  0.393
2009 Lin CI, Whang EE, Abramson MA, Donner DB, Bertagnolli MM, Moore FD, Ruan DT. Galectin-3 regulates apoptosis and doxorubicin chemoresistance in papillary thyroid cancer cells. Biochemical and Biophysical Research Communications. 379: 626-31. PMID 19124005 DOI: 10.1016/J.Bbrc.2008.12.153  0.369
2009 Wang Y, Zuraek M, Donner D, Bergsland E, Warren R, Nakakura E. QS138. The FEV Transcription Factor is Abberantly Expressed in Neuroendocrine Tumors of the Small Intestine Journal of Surgical Research. 151: 288. DOI: 10.1016/J.Jss.2008.11.435  0.316
2008 Pincheira R, Donner DB. The Sall2 transcription factor is a novel p75NTR binding protein that promotes the development and function of neurons. Annals of the New York Academy of Sciences. 1144: 53-5. PMID 19076363 DOI: 10.1196/Annals.1418.026  0.336
2008 Ruan DT, Warren RS, Moalem J, Chung KW, Griffin AC, Shen W, Duh QY, Nakakura E, Donner DB, Khanafshar E, Weng J, Clark OH, Kebebew E. Mitogen-inducible gene-6 expression correlates with survival and is an independent predictor of recurrence in BRAF(V600E) positive papillary thyroid cancers. Surgery. 144: 908-13; discussion 9. PMID 19040996 DOI: 10.1016/J.Surg.2008.07.028  0.344
2008 Pincheira R, Castro AF, Ozes ON, Idumalla PS, Donner DB. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. Journal of Immunology (Baltimore, Md. : 1950). 181: 1288-98. PMID 18606683 DOI: 10.4049/Jimmunol.181.2.1288  0.522
2007 LaRusch GA, Jackson MW, Dunbar JD, Warren RS, Donner DB, Mayo LD. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2. Cancer Research. 67: 450-4. PMID 17234751 DOI: 10.1158/0008-5472.Can-06-2710  0.383
2007 Matei D, Satpathy M, Cao L, Lai YC, Nakshatri H, Donner DB. The platelet-derived growth factor receptor alpha is destabilized by geldanamycins in cancer cells. The Journal of Biological Chemistry. 282: 445-53. PMID 17079230 DOI: 10.1074/Jbc.M607012200  0.436
2006 Jackson MW, Patt LE, LaRusch GA, Donner DB, Stark GR, Mayo LD. Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells. The Journal of Biological Chemistry. 281: 16814-20. PMID 16621805 DOI: 10.1074/Jbc.M511617200  0.508
2006 Gustin JA, Korgaonkar CK, Pincheira R, Li Q, Donner DB. Akt regulates basal and induced processing of NF-kappaB2 (p100) to p52. The Journal of Biological Chemistry. 281: 16473-81. PMID 16613850 DOI: 10.1074/Jbc.M507373200  0.781
2006 Schmidt NW, Mayo LD, Donner DB, Kaplan MH. p53 regulates Btk-dependent B cell proliferation but not differentiation. Journal of Leukocyte Biology. 79: 852-9. PMID 16461747 DOI: 10.1189/Jlb.0705402  0.309
2005 Matei D, Lai YC, Rao J, Emerson R, Donner D. PDGFR is activated through an autocrine mechanism in ovarian cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 5073. PMID 27946328 DOI: 10.1200/Jco.2005.23.16_Suppl.5073  0.32
2005 Mayo LD, Seo YR, Jackson MW, Smith ML, Rivera Guzman J, Korgaonkar CK, Donner DB. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. The Journal of Biological Chemistry. 280: 25953-9. PMID 15843377 DOI: 10.1074/Jbc.M503026200  0.403
2005 Ozes ON, Akca H, Gustin JA, Mayo LD, Pincheira R, Korgaonkar CK, Donner DB. Tumor necrosis factor-α/receptor signaling through the Akt kinase Cell Signaling in Vascular Inflammation. 13-22. DOI: 10.1007/978-1-59259-909-7_2  0.759
2004 Gustin JA, Pincheira R, Mayo LD, Ozes ON, Kessler KM, Baerwald MR, Korgaonkar CK, Donner DB. Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells. American Journal of Physiology. Cell Physiology. 286: C547-55. PMID 14761884 DOI: 10.1152/Ajpcell.00332.2002  0.799
2004 Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, Guzman JR, Korgaonkar CK, Donner DB. Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. The Journal of Biological Chemistry. 279: 1615-20. PMID 14585846 DOI: 10.1074/Jbc.M306976200  0.781
2003 Su JD, Mayo LD, Donner DB, Durden DL. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Research. 63: 3585-92. PMID 12839945  0.353
2002 Mayo LD, Donner DB. The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends in Biochemical Sciences. 27: 462-7. PMID 12217521 DOI: 10.1016/S0968-0004(02)02166-7  0.449
2002 Wang D, Lehman RE, Donner DB, Matli MR, Warren RS, Welton ML. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology. 282: G1088-96. PMID 12016135 DOI: 10.1152/Ajpgi.00250.2001  0.352
2002 Mayo LD, Dixon JE, Durden DL, Tonks NK, Donner DB. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. The Journal of Biological Chemistry. 277: 5484-9. PMID 11729185 DOI: 10.1074/Jbc.M108302200  0.437
2001 Mayo LD, Donner DB. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proceedings of the National Academy of Sciences of the United States of America. 98: 11598-603. PMID 11504915 DOI: 10.1073/Pnas.181181198  0.512
2001 Gustin JA, Maehama T, Dixon JE, Donner DB. The PTEN Tumor Suppressor Protein Inhibits Tumor Necrosis Factor-induced Nuclear Factor κB Activity Journal of Biological Chemistry. 276: 27740-27744. PMID 11356844 DOI: 10.1074/Jbc.M102559200  0.799
2001 Mayo LD, Kessler KM, Pincheira R, Warren RS, Donner DB. Vascular endothelial cell growth factor activates CRE-binding protein by signaling through the KDR receptor tyrosine kinase. The Journal of Biological Chemistry. 276: 25184-9. PMID 11335727 DOI: 10.1074/Jbc.M102932200  0.52
2001 Ozes ON, Akca H, Mayo LD, Gustin JA, Maehama T, Dixon JE, Donner DB. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proceedings of the National Academy of Sciences of the United States of America. 98: 4640-5. PMID 11287630 DOI: 10.1073/Pnas.051042298  0.769
2001 Yang CH, Murti A, Pfeffer SR, Kim JG, Donner DB, Pfeffer LM. Interferon alpha /beta promotes cell survival by activating nuclear factor kappa B through phosphatidylinositol 3-kinase and Akt. The Journal of Biological Chemistry. 276: 13756-61. PMID 11278812 DOI: 10.1074/jbc.M011006200  0.407
2000 Guo DQ, Wu LW, Dunbar JD, Ozes ON, Mayo LD, Kessler KM, Gustin JA, Baerwald MR, Jaffe EA, Warren RS, Donner DB. Tumor necrosis factor employs a protein-tyrosine phosphatase to inhibit activation of KDR and vascular endothelial cell growth factor-induced endothelial cell proliferation. The Journal of Biological Chemistry. 275: 11216-21. PMID 10753929 DOI: 10.1074/Jbc.275.15.11216  0.78
2000 Wang D, Donner DB, Warren RS. Homeostatic modulation of cell surface KDR and Flt1 expression and expression of the vascular endothelial cell growth factor (VEGF) receptor mRNAs by VEGF. The Journal of Biological Chemistry. 275: 15905-11. PMID 10748050 DOI: 10.1074/Jbc.M001847200  0.402
2000 Wu LW, Mayo LD, Dunbar JD, Kessler KM, Ozes ON, Warren RS, Donner DB. VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor. The Journal of Biological Chemistry. 275: 6059-62. PMID 10692392 DOI: 10.1074/Jbc.275.9.6059  0.393
2000 Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, Donner DB. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. The Journal of Biological Chemistry. 275: 5096-103. PMID 10671553 DOI: 10.1074/Jbc.275.7.5096  0.51
2000 Nidai Ozes O, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. reply: Kinase regulation in inflammatory response Nature. 406: 368-368. DOI: 10.1038/35019157  0.759
1999 Pazdernik NJ, Donner DB, Goebl MG, Harrington MA. Mouse receptor interacting protein 3 does not contain a caspase- recruiting or a death domain but induces apoptosis and activates NF-κB Molecular and Cellular Biology. 19: 6500-6508. PMID 10490590 DOI: 10.1128/Mcb.19.10.6500  0.447
1999 Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature. 401: 82-5. PMID 10485710 DOI: 10.1038/43466  0.788
1999 Wu LW, Reid S, Ritchie A, Broxmeyer HE, Donner DB. The proteasome regulates caspase-dependent and caspase-independent protease cascades during apoptosis of MO7e hematopoietic progenitor cells. Blood Cells, Molecules & Diseases. 25: 20-9. PMID 10349510 DOI: 10.1006/Bcmd.1999.0223  0.347
1999 Vig E, Green M, Liu Y, Donner DB, Mukaida N, Goebl MG, Harrington MA. Modulation of tumor necrosis factor and interleukin-1-dependent NF-κB activity by mPLK/IRAK Journal of Biological Chemistry. 274: 13077-13084. PMID 10224059 DOI: 10.1074/Jbc.274.19.13077  0.482
1998 Ankoma-Sey V, Matli M, Chang KB, Lalazar A, Donner DB, Wong L, Warren RS, Friedman SL. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene. 17: 115-21. PMID 9671320 DOI: 10.1038/Sj.Onc.1201912  0.394
1996 Warren RS, Yuan H, Matli MR, Ferrara N, Donner DB. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. The Journal of Biological Chemistry. 271: 29483-8. PMID 8910616 DOI: 10.1074/Jbc.271.46.29483  0.374
1996 Marino MW, Dunbar JD, Wu LW, Ngaiza JR, Han HM, Guo D, Matsushita M, Nairn AC, Zhang Y, Kolesnick R, Jaffe EA, Donner DB. Inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine. The Journal of Biological Chemistry. 271: 28624-9. PMID 8910494 DOI: 10.1074/Jbc.271.45.28624  0.559
1996 Broxmeyer HE, Cooper S, Li ZH, Lu L, Sarris A, Wang MH, Chang MS, Donner DB, Leonard EJ. Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Annals of Hematology. 73: 1-9. PMID 8695717 DOI: 10.1007/S002770050192  0.41
1996 Broxmeyer HE, Cooper S, Li ZH, Lu L, Song HY, Kwon BS, Warren RE, Donner DB. Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. International Journal of Hematology. 62: 203-15. PMID 8589366 DOI: 10.1016/0925-5710(95)00412-2  0.373
1996 Guo D, Donner DB. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. The Journal of Biological Chemistry. 271: 615-8. PMID 8557661 DOI: 10.1074/Jbc.271.2.615  0.493
1995 Guo D, Jia Q, Song HY, Warren RS, Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. The Journal of Biological Chemistry. 270: 6729-33. PMID 7896817 DOI: 10.1074/Jbc.270.12.6729  0.461
1995 Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. The Journal of Biological Chemistry. 270: 3574-81. PMID 7876093 DOI: 10.1074/Jbc.270.8.3574  0.392
1995 Blumberg D, Tsuburaya A, Burt M, Donner DB, Brennan MF. Acute metabolic effects of human recombinant tumor necrosis factor beta in the rat. Annals of Surgical Oncology. 1: 373-7. PMID 7850538 DOI: 10.1007/Bf02303808  0.307
1995 Song HY, Donner DB. Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor. The Biochemical Journal. 825-9. PMID 7639698 DOI: 10.1042/Bj3090825  0.358
1995 Blumberg D, Hochwald S, Burt M, Donner D, Brennan MF. Tumor necrosis factor alpha stimulates gluconeogenesis from alanine in vivo. Journal of Surgical Oncology. 59: 220-4; discussion 22. PMID 7630167 DOI: 10.1002/Jso.2930590404  0.313
1993 Manchester KM, Heston WD, Donner DB. Tumour necrosis factor-induced cytotoxicity is accompanied by intracellular mitogenic signals in ME-180 human cervical carcinoma cells. The Biochemical Journal. 185-90. PMID 8439287 DOI: 10.1042/Bj2900185  0.433
1992 Kinouchi K, Brown G, Pasternak G, Donner DB. Identification and characterization of receptors for tumor necrosis factor-alpha in the brain. Biochemical and Biophysical Research Communications. 181: 1532-8. PMID 1662500 DOI: 10.1016/0006-291X(91)92113-X  0.326
1989 Marino MW, Pfeffer LM, Guidon PT, Donner DB. Tumor necrosis factor induces phosphorylation of a 28-kDa mRNA cap-binding protein in human cervical carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 8417-21. PMID 2813400 DOI: 10.1073/Pnas.86.21.8417  0.42
1989 Lipson KE, Kolhatkar AA, Donner DB. Insulin stimulates proteolysis of the alpha-subunit, but not the beta-subunit, of its receptor at the cell surface in rat liver. The Biochemical Journal. 261: 333-40. PMID 2673219 DOI: 10.1042/Bj2610333  0.315
1989 Lipson KE, Kolhatkar AA, Donner DB. Alkylation, reduction, solubilization and enrichment of binding activity do not impair the ability of insulin receptors to convert from a rapid- into a slow-dissociating state. The Biochemical Journal. 259: 871-8. PMID 2658980 DOI: 10.1042/Bj2590871  0.315
1988 Meyers MB, Shen WP, Spengler BA, Ciccarone V, O'Brien JP, Donner DB, Furth ME, Biedler JL. Increased epidermal growth factor receptor in multidrug-resistant human neuroblastoma cells. Journal of Cellular Biochemistry. 38: 87-97. PMID 2464605 DOI: 10.1002/Jcb.240380203  0.327
1987 Yamada K, Lipson KE, Marino MW, Donner DB. Effect of growth hormone on protein phosphorylation in isolated rat hepatocytes. Biochemistry. 26: 715-21. PMID 3567143 DOI: 10.1021/Bi00377A009  0.379
1987 Lipson KE, Kolhatkar AA, Dorato A, Donner DB. N-ethylmaleimide uncouples the glucagon receptor from the regulatory component of adenylyl cyclase. Biochemistry. 25: 5678-85. PMID 3022802 DOI: 10.1021/Bi00367A050  0.302
1987 Pfeffer LM, Stebbing N, Donner DB. Cytoskeletal association of human alpha-interferon-receptor complexes in interferon-sensitive and -resistant lymphoblastoid cells. Proceedings of the National Academy of Sciences of the United States of America. 84: 3249-53. PMID 2953024 DOI: 10.1073/Pnas.84.10.3249  0.306
1987 Warren RS, Donner DB, Starnes HF, Brennan MF. Modulation of endogenous hormone action by recombinant human tumor necrosis factor. Proceedings of the National Academy of Sciences of the United States of America. 84: 8619-22. PMID 2825198 DOI: 10.1073/Pnas.84.23.8619  0.329
1985 Yamada K, Donner DB. Evidence that non-covalent forces, thiol and disulphide groups affect the structure and binding properties of the prolactin receptor on hepatocytes from pregnant rats. The Biochemical Journal. 228: 383-90. PMID 2990446 DOI: 10.1042/Bj2280383  0.306
1983 Corin RE, Bancroft FC, Sonenberg M, Donner DB. Binding and degradation of 125I-labeled insulin by a clonal line of rat pituitary tumor cells. Biochimica Et Biophysica Acta. 762: 503-11. PMID 6347260 DOI: 10.1016/0167-4889(83)90053-8  0.306
1977 Fu JL, Donner DB, Moore DE, Hess GP. Allosteric interactions between the membrane-bound acetylcholine receptor and chemical mediators: equilibrium measurements. Biochemistry. 16: 678-84. PMID 836807 DOI: 10.1021/Bi00623A019  0.337
Show low-probability matches.